Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A
Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A
Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A
Submitted by
admin
on July 8, 2012 - 1:26pm
Source:
news.genom.es
News Tags:
Bayer
hemophilia
BAY94-9027
Headline:
Bayer Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A
Do Not Allow Advertisers to Use My Personal information
